Parsaclisib
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Parsaclisib, covering 2022-02-14 to 2026-02-02. Get the full timeline:
Most recent: Clinical Trial Update: Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma [Phase 1]